RAB26 and breast carcinoma: To verify whether Rab26 inhibits the migration/invasion of breast cancer cells through downregulating phosphorylated Src, the phosphorylated Src was replenished in MDA-MB-231 cells stably expressing Rab26 by transfection with the constitutive active Src (SrcCA) (Fig. 5A).